Home » Stocks » WST

West Pharmaceutical Services, Inc. (WST)

Stock Price: $333.07 USD 4.77 (1.45%)
Updated May 14, 2021 4:00 PM EDT - Market closed
Market Cap 24.59B
Revenue (ttm) 2.33B
Net Income (ttm) 423.10M
Shares Out 73.90M
EPS (ttm) 5.57
PE Ratio 59.82
Forward PE 47.85
Dividend $0.66
Dividend Yield 0.20%
Trading Day May 14
Last Price $333.07
Previous Close $328.30
Change ($) 4.77
Change (%) 1.45%
Day's Open 330.83
Day's Range 327.33 - 334.61
Day's Volume 261,964
52-Week Range 194.89 - 339.65

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

West Pharmaceutical (WST) possesses solid growth attributes, which could help it handily outperform the market.

2 days ago - Zacks Investment Research

For a prudent investor, a safe strategy of choosing stocks should include search for stocks that bear a low leverage. You may buy DQ, LPX, NUE, WST and PHM.

Other stocks mentioned: DQ, LPX, NUE, PHM
1 week ago - Zacks Investment Research

EXTON, Pa., May 5, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Boa...

1 week ago - PRNewsWire

This may be a good time to invest in growth stocks.

Other stocks mentioned: AAPL, GNRC, GOOGL, MKSI
1 week ago - Zacks Investment Research

West Pharmaceutical (WST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

2 weeks ago - Zacks Investment Research

Shares of West Pharmaceutical Servs (NYSE:WST) fell 0.3% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 102.97% year over year to $2.05, which bea...

2 weeks ago - Benzinga

EXTON, Pa., April 29, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2021 and updated full-year 2021 financial guidance. ...

2 weeks ago - PRNewsWire

West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 weeks ago - Zacks Investment Research

The stocks of the future may also be good for your investment returns in the present.

Other stocks mentioned: BAC, BBY, BLK, ESGU, ESGV, NVDA, SPYX
3 weeks ago - The Motley Fool

EXTON, Pa., April 15, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will releas...

4 weeks ago - PRNewsWire

New York, New York--(Newsfile Corp. - March 31, 2021) - Levi & Korsinsky announces it has commenced an investigation of West Pharmaceutical Services, Inc. (NYSE: WST) concerning possible breaches of fid...

1 month ago - Newsfile Corp

EXTON, Pa., March 17, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that management will present virtually at the KeyBanc Capital Markets Life Sciences & MedTech Investor...

1 month ago - PRNewsWire

3 Stocks to Capitalize on Promising Dental Supplies Industry

Other stocks mentioned: ABC, ALGN, BDX, CAH, COO, HSIC, LH ...
2 months ago - Zacks Investment Research

ESG investing will continue its northward momentum and this calls for investing in NVIDIA (NVDA), Microsoft (MSFT), EMCOR (EME), West Pharma (WST) and Texas Instruments (TXN)

Other stocks mentioned: EME, MSFT, NVDA, TXN
2 months ago - Zacks Investment Research

EXTON, Pa., Feb. 24, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's B...

2 months ago - PRNewsWire

West Pharmaceutical (WST) delivered earnings and revenue surprises of 18.58% and 7.04%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Shares of West Pharmaceutical Servs (NYSE:WST) moved higher by 0.1% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 63.41% year over year to $1.34,...

2 months ago - Benzinga

EXTON, Pa., Feb. 18, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter, full-year 2020 and introduced full-year 2021 financ...

2 months ago - PRNewsWire

EXTON, Pa., Feb. 4, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release ...

3 months ago - PRNewsWire

Their financial strength and profitability have received high ratings.

Other stocks mentioned: GRMN, TER
3 months ago - GuruFocus

West is currently prepping and delivering products and services needed for the Covid-19 vaccine. Holds a leadership position as a pick and shovel play to the pharmaceutical market.

4 months ago - Seeking Alpha

The Covid-19 vaccine rally isn't just limited to biotech firms. Here are the top coronavirus stocks that are making mass vaccination possible.

Other stocks mentioned: AVTR, BDX, JNJ, MRNA, PFE, TMO
4 months ago - InvestorPlace

Stocks hold near highs: Axon Breaks Out; AMD, West Pharmaceutical Near Key Levels

YouTube video

Stocks hold near highs: Axon breaks out; AMD, West Pharmaceutical near key levels. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing ...

Other stocks mentioned: AMD, AAXN
4 months ago - Investors Business Daily

If you're preparing for another market crash, don't overlook these rock star stocks.

Other stocks mentioned: AAPL, SNAP
4 months ago - The Motley Fool

Here are a few MedTech stocks which continued to outperform their respective industries amid the pandemic and can turn out to be wise investment choices.

Other stocks mentioned: HOLX, IDXX, RMD, TMO
4 months ago - Zacks Investment Research

Buy these three top dental stocks that have shown sharp recovery despite market volatility due to the pandemic, and have the potential to continue their bull run in 2021.

Other stocks mentioned: ALGN, PDCO
4 months ago - Zacks Investment Research

MCK vs. WST: Which Stock Is the Better Value Option?

Other stocks mentioned: MCK
5 months ago - Zacks Investment Research

Is (WST) Outperforming Other Medical Stocks This Year?

5 months ago - Zacks Investment Research

EXTON, Pa., Dec. 9, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Bo...

5 months ago - PRNewsWire

There are plenty of healthcare stocks that have seen share growth this year. Here are three lesser-known stocks that have the potential to continue that growth this month and beyond.

Other stocks mentioned: FLGT, FPRX
5 months ago - The Motley Fool

Is (WST) Outperforming Other Medical Stocks This Year?

5 months ago - Zacks Investment Research

Even when a coronavirus vaccine is ready, distribution could be a challenge -- but recent innovations in medical glass could benefit the public and investors alike.

Other stocks mentioned: AZN, BNTX, GLW, MRNA, PFE
5 months ago - The Motley Fool

With COVID-19 vaccine on the horizon, cold-chain storage stocks including TT, CARR and TMO; vial makers like GLW and WST; and logistic operators including UPS and FDX are set to hog the limelight.

Other stocks mentioned: CARR, FDX, GLW, TMO, TT, UPS
5 months ago - Zacks Investment Research

Is (WST) Outperforming Other Medical Stocks This Year?

6 months ago - Zacks Investment Research

EXTON, Pa., Nov. 9, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced it has appointed Kimberly B...

6 months ago - PRNewsWire

While vaccine makers hog the headlines, these equipment providers are critical to the global supply chain.

Other stocks mentioned: TMO
6 months ago - The Motley Fool

ABC vs. WST: Which Stock Is the Better Value Option?

Other stocks mentioned: ABC
6 months ago - Zacks Investment Research

3 Dental Supplies Stocks Set to Shine on the Industry's Upturn

Other stocks mentioned: ABC, ALGN, BDX, CAH, COO, HSIC, LH ...
6 months ago - Zacks Investment Research

EXTON, Pa., Oct. 28, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's B...

6 months ago - PRNewsWire

EXTON, Pa., Oct. 22, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), West Pharmaceutical Services, Inc. (West) is pleased to announce FDA 510(k) clearance and launch of its Vial2Bag...

6 months ago - PRNewsWire

West Pharmaceutical Services' (WST) CEO Eric Green on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

West Pharmaceutical (WST) delivered earnings and revenue surprises of 13.86% and 7.20%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Shares of West Pharmaceutical Servs (NYSE:WST) rose 0.3% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share increased 45.57% over the past year to $1.15, w...

6 months ago - Benzinga

West Pharmaceutical earnings beat views, with the IBD 50 coronavirus play also guiding higher. WST stock is just below a buy point.

6 months ago - Investors Business Daily

EXTON, Pa., Oct. 22, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2020 and updated full-year 2020 financial guidance. T...

6 months ago - PRNewsWire

West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

MCK vs. WST: Which Stock Is the Better Value Option?

Other stocks mentioned: MCK
7 months ago - Zacks Investment Research

EXTON, Pa., Oct. 8, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release ...

7 months ago - PRNewsWire

As the race to develop a vaccine continues, these biotech stocks could be high risk, high return propositions. The post 7 Biotech Stocks To Buy For Profit From The Vaccine Crunch appeared first on Inves...

Other stocks mentioned: GILD, FBT, GERM, PFE, REGN
7 months ago - InvestorPlace

Stocks Dive As Trump Ends Stimulus Talks, West Pharmaceutical, BlackLine, Sea Limited Break Out

YouTube video

Stocks dive as Trump ends stimulus talks; West Pharmaceutical, BlackLine, Sea break out. Investor’s Business Daily has been helping people invest smarter results by providing exclusive stock lists, inve...

Other stocks mentioned: BL, SE
7 months ago - Investors Business Daily

About WST

West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance t... [Read more...]

Industry
Medical Instruments & Supplies
Founded
1923
CEO
Eric Green
Employees
9,200
Stock Exchange
NYSE
Ticker Symbol
WST
Full Company Profile

Financial Performance

In 2020, WST's revenue was $2.15 billion, an increase of 16.69% compared to the previous year's $1.84 billion. Earnings were $346.20 million, an increase of 43.24%.

Financial Statements

Analyst Forecasts

According to 7 analysts, the average rating for WST stock is "Buy." The 12-month stock price forecast is 351.60, which is an increase of 5.56% from the latest price.

Price Target
$351.60
(5.56% upside)
Analyst Consensus: Buy